3-[[(2S)-2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]methyl]-N,N-dimethyl-1,2,4-oxadiazole-5-carboxamide
C17H19N5O2S — CID 95720222
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[(2S)-2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]methyl]-N,N-dimethyl-1,2,4-oxadiazole-5-carboxamide
3-[[(2S)-2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]methyl]-N,N-dimethyl-1,2,4-oxadiazole-5-carboxamide (PubChem CID 95720222) has the molecular formula C17H19N5O2S and a molecular weight of 357.44 g/mol. Its IUPAC name is 3-[[(2S)-2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]methyl]-N,N-dimethyl-1,2,4-oxadiazole-5-carboxamide.
Molecular Properties
| Compound Name | 3-[[(2S)-2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]methyl]-N,N-dimethyl-1,2,4-oxadiazole-5-carboxamide |
|---|---|
| PubChem CID | 95720222 |
| Molecular Formula | C17H19N5O2S |
| Molecular Weight | 357.44 g/mol |
| Exact Mass | 357.13 |
| IUPAC Name | 3-[[(2S)-2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]methyl]-N,N-dimethyl-1,2,4-oxadiazole-5-carboxamide |
| SMILES | CN(C)C(=O)c1nc(CN2CCC[C@H]2c2nc3ccccc3s2)no1 |
| InChI | InChI=1S/C17H19N5O2S/c1-21(2)17(23)15-19-14(20-24-15)10-22-9-5-7-12(22)16-18-11-6-3-4-8-13(11)25-16/h3-4,6,8,12H,5,7,9-10H2,1-2H3/t12-/m0/s1 |
| InChIKey | KQOCUIPKVBOJSC-LBPRGKRZSA-N |
| XLogP | 2.72 |
| TPSA | 75.36 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 357.44 |
| LogP ≤ 5 | 2.72 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 95720222 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.